A Prospective Pilot Trial to Assess the Efficacy of Argatroban (Argatra<sup>®</sup>) in Critically Ill Patients with Heparin Resistance <xref rid="fn1-jcm-748765" ref-type="fn">†</xref>

A Prospective Pilot Trial to Assess the Efficacy of Argatroban (Argatra<sup>®</sup>) in Critically Ill Patients with Heparin Resistance <xref rid="fn1-jcm-748765" ref-type="fn">†</xref>

The current study aims to evaluate whether prophylactic anticoagulation using argatroban or an increased dose of unfractionated heparin (UFH) is effective in achieving the targeted activated partial thromboplastin time (aPTT) of more than 45 s in critically ill heparin-resistant (HR) patients. Patie...

Full description

Bibliographic Details
Main Authors: Mirjam Bachler, Tobias Hell, Johannes Bösch, Benedikt Treml, Bettina Schenk, Benjamin Treichl, Barbara Friesenecker, Ingo Lorenz, Daniel Stengg, Stefan Hruby, Bernd Wallner, Elgar Oswald, Mathias Ströhle, Christian Niederwanger, Christian Irsara, Dietmar Fries
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:Journal of Clinical Medicine
Subjects:
Argatroban
hemorrhage
critical illness
prophylactic anticoagulation
thrombosis
unfractionated heparin
Online Access:https://www.mdpi.com/2077-0383/9/4/963

Internet

https://www.mdpi.com/2077-0383/9/4/963

Similar Items